Home
Issues
2018
April 2018, Vol 7, No 1
2017
December 2017, Vol 6, No 5
October 2017, Vol 6, No 4
August 2017, Vol 6, No 3
June 2017, Vol 6, No 2
April 2017, Vol 6, No 1
2016
December 2016, Vol 5, No 6
October 2016, Vol 5, No 5
August 2016, Vol 5, No 4
June 2016, Vol 5, No 3
April 2016, Vol 5, No 2
February 2016, Vol 5, No 1
Issues Archive
Supplements
Categories
Web Exclusives
All Web Exclusives
FDA Approvals, News & Updates
In The News
Online First
Videos
About
About VBCR
About Engage HC
Contact Us
Editorial/Publishing Policies
Editorial Board
Advertising Contacts
Advertising Policy
Author Guidelines
Thursday, 28 March 2024
Authored Items
Tocilizumab Demonstrates Success in the Treatment of Patients with Giant Cell Arteritis
Phoebe Starr
VBCR - December 2016, Vol 5, No 6
in
Giant Cell Arteritis
Rituximab Maintenance Outshines Azathioprine for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
Phoebe Starr
VBCR - December 2016, Vol 5, No 6
in
Vasculitis
Cost of Drugs and Affordability Don’t Always Jibe
Phoebe Starr
VBCC - July 2016, Vol 7, No 6
in
Value in Oncology
Usefulness of Vitamin D Supplementation Questioned in Patients with Knee Osteoarthritis
Phoebe Starr
VBCR - June 2016, Vol 5, No 3
in
Osteoarthritis
Baricitinib Effective in Patients with Refractory Rheumatoid Arthritis
Phoebe Starr
VBCR - June 2016, Vol 5, No 3
in
Rheumatoid Arthritis
Vaccine Uptake Remains Low in Patients with RA
Phoebe Starr
VBCR - June 2016, Vol 5, No 3
in
Health & Wellness
Age, Smoking History Are Risk Factors for Early Organ Damage in Patients with SLE
Phoebe Starr
VBCR - June 2016, Vol 5, No 3
in
Lupus
IL-6 Inhibitor Shows Promise in Patients with PsA
Phoebe Starr
VBCR - June 2016, Vol 5, No 3
in
Psoriatic Arthritis
ESR1 Mutations Predict Worse Survival in ER-Positive Advanced Breast Cancer
Phoebe Starr
VBCC - June 2016, Vol 7, No 5
in
Personalized Medicine
Early Results of Immunotherapy in Breast Cancer
Phoebe Starr
VBCC - June 2016, Vol 7, No 5
in
Breast Cancer
Real-World Data Show 2-Year Survival Predicts Long-Term Survival for Metastatic Germ-Cell Testicular Cancer
Phoebe Starr
VBCC - June 2016, Vol 7, No 5
in
Genitourinary Cancers
Cabozantinib Improves on Standard of Care for Second-Line Treatment of Patients with Advanced Renal-Cell Carcinoma
Phoebe Starr
VBCC - May 2016, Vol 7, No 4
in
Genitourinary Cancers
Omit Chemotherapy for Luminal A Breast Cancer?
Phoebe Starr
VBCC - May 2016, Vol 7, No 4
in
Breast Cancer
Additional Chemotherapy Improves Survival in Women with Residual Disease After Neoadjuvant Chemotherapy
Phoebe Starr
VBCC - May 2016, Vol 7, No 4
in
Breast Cancer
Self-Reports of 6-Mercaptopurine Intake in Childhood Acute Lymphoblastic Leukemia Unreliable
Phoebe Starr
Web Exclusives
in
Hematologic Cancers
Fracture of Proximal Bones Often Harbinger of Premature Death
Phoebe Starr
VBCR - April 2016, Vol 5, No 2
in
Rheumatology Update
Ultrasound Not Necessary in T2T Strategy
Phoebe Starr
VBCR - April 2016, Vol 5, No 2
in
Rheumatology Update
Genomics May Explain Poor Survival of African Americans with Kidney Cancer
Phoebe Starr
VBCC - April 2016, Vol 7, No 3
in
Personalized Medicine
Biomarker for Uveal Melanoma Has Immediate Clinical Impact
Phoebe Starr
VBCC - April 2016, Vol 7, No 3
in
Personalized Medicine
Another Study Shows Benefit of Pediatric Regimen in Young Adults with Acute Lymphoblastic Leukemia
Phoebe Starr
VBCC - April 2016, Vol 7, No 3
in
Hematologic Malignancies
Reirradiation of Pelvic Area Safe, Improves Quality of Life
Phoebe Starr
VBCC - April 2016, Vol 7, No 3
in
Genitourinary Cancers
Survival Benefit for T-DM1 Confirmed in Metastatic Breast Cancer
Phoebe Starr
VBCC - April 2016, Vol 7, No 3
in
Breast Cancer
Tamoxifen or Anastrozole for DCIS? Age and Symptoms Matter
Phoebe Starr
VBCC - April 2016, Vol 7, No 3
in
Breast Cancer
Liquid Biopsy Characterizing Circulating Tumor Cells Can Aid Treatment Selection in Prostate Cancer
Phoebe Starr
VBCC - March 2016, Vol 7, No 2
in
Personalized Medicine
Inotuzumab Ozogamicin Shows Promise in Older Patients with Acute Lymphoblastic Leukemia
Phoebe Starr
VBCC - March 2016, Vol 7, No 2
in
Emerging Therapies
Myeloablative Conditioning Remains Standard of Care in Patients with Myelodysplastic Syndrome
Phoebe Starr
VBCC - March 2016, Vol 7, No 2
in
Hematologic Malignancies
Regular Aspirin Use Reduces the Risk for Prostate Cancer Death
Phoebe Starr
VBCC - March 2016, Vol 7, No 2
in
Prostate Cancer
Midostaurin the First Targeted Therapy to Improve Survival in AML: Potentially Practice-Changing
Phoebe Starr
VBCC - February 2016, Vol 7, No 1
in
Emerging Therapies
The Hematologic Drug Pipeline: Exciting New Treatment Options Looming
Phoebe Starr
VBCC - February 2016, Vol 7, No 1
in
Emerging Therapies
Idelalisib Improves Survival When Added to Bendamustine plus Rituximab in Patients with CLL
Phoebe Starr
VBCC - February 2016, Vol 7, No 1
in
Leukemia Highlights
Ibrutinib a New Standard of Care for Elderly Patients with Chronic Lymphocytic Leukemia
Phoebe Starr
VBCC - February 2016, Vol 7, No 1
in
Leukemia Highlights
Checkpoint Inhibitors in Lymphoma: A New Universe
Phoebe Starr
VBCC - February 2016, Vol 7, No 1
in
Lymphoma Highlights
Venetoclax Shows Strong Activity in CLL
Phoebe Starr
VBCC - February 2016, Vol 7, No 1
in
Emerging Therapies
Genomic Test Supports Treatment Decisions in Prostate Cancer
Phoebe Starr
VBCC - December 2015, Vol 6, No 11
in
Personalized Medicine
Teamwork Improves End-of-Life Care, Saves Money
Phoebe Starr
VBCC - December 2015, Vol 6, No 11
in
Palliative Care
Treat-to-Target Strategy for Rheumatoid Arthritis
Phoebe Starr
VBCR - December 2015, Volume 4, No 6
in
Rheumatoid Arthritis
Chikungunya: Coming to the United States
Phoebe Starr
VBCR - December 2015, Volume 4, No 6
in
Differential Diagnosis
Biosimilar Performs as Well as Adalimumab
Phoebe Starr
VBCR - December 2015, Volume 4, No 6
in
Rheumatoid Arthritis
For TNF-Experienced Patients with RA, Switching to Anti-TNF Saves Resources, Costs
Phoebe Starr
VBCR - December 2015, Volume 4, No 6
in
Rheumatoid Arthritis
Chondroitin: Safe, Inexpensive, Reduces Knee Damage
Phoebe Starr
VBCR - December 2015, Volume 4, No 6
in
Knee Osteoarthritis
Steroid Injections Do Not Harm Knee Joint
Phoebe Starr
VBCR - December 2015, Volume 4, No 6
in
Knee Osteoarthritis
Benefit of Booster Exercise for Patients with Knee Osteoarthritis
Phoebe Starr
VBCR - December 2015, Volume 4, No 6
in
Knee Osteoarthritis
Dramatic Weight Loss Improves Psoriatic Arthritis
Phoebe Starr
VBCR - December 2015, Volume 4, No 6
in
Psoriatic Arthritis
Everolimus, 177Lu-DOTATATE Potentially 2 Practice-Changing Options in NETs
Phoebe Starr
VBCC - November 2015, Vol 6, No 10
in
Emerging Therapies
Significant Benefits Seen with 2 New Options for Patients with Renal-Cell Carcinoma
Phoebe Starr
VBCC - November 2015, Vol 6, No 10
in
Emerging Therapies
Chemotherapy Safe During Pregnancy in Second and Third Trimesters
Phoebe Starr
VBCC - November 2015, Vol 6, No 10
in
Pregnancy & Cancer
Men’s Health Supplements Have No Value for Patients with Prostate Cancer
Phoebe Starr
VBCC - November 2015, Vol 6, No 10
in
Prostate Cancer
Patients with Early Breast Cancer and Low Oncotype DX Scores Can Skip Chemotherapy
Phoebe Starr
VBCC - October 2015, Vol 6, No 9
in
Breast Cancer
Atezolizumab: Another Immunotherapy for Lung Cancer?
Phoebe Starr
VBCC - October 2015, Vol 6, No 9
in
Emerging Therapies
Nivolumab Beats Docetaxel as Second-Line Therapy for Patients with NSCLC
Phoebe Starr
VBCC - August 2015, Vol 6, No 7
in
Emerging Therapies
GADOLIN Trial: Obinutuzumab an Effective Treatment for Indolent Lymphoma
Phoebe Starr
VBCC - August 2015, Vol 6, No 7
in
Emerging Therapies
Combination of PARP and PI3K Inhibitors Share a Genomic Landscape in Breast and Ovarian Cancers
Phoebe Starr
VBCC - August 2015, Vol 6, No 7
in
Personalized Medicine
Genetic Abnormality Pinpointed for Intensive Therapy in Wilms Tumor
Phoebe Starr
VBCC - July 2015, Vol 6, No 6
in
ASCO 2015 Highlights
Elotuzumab, First-in-Class Monoclonal Antibody Immunotherapy, Improves Outcomes in Patients with Multiple Myeloma
Phoebe Starr
VBCC - June 2015, Vol 6, No 5
in
ASCO 2015 Highlights
Encouraging Results for Pembrolizumab in Head and Neck Cancer
Phoebe Starr
VBCC - June 2015, Vol 6, No 5
in
ASCO 2015 Highlights
Oral Nicotinamide Prevents Common Skin Cancers in High-Risk Patients
Phoebe Starr
VBCC - June 2015, Vol 6, No 5
in
ASCO 2015 Highlights
Docetaxel Boosts Survival in Patients with Hormone-Naïve Metastatic Prostate Cancer
Phoebe Starr
VBCC - June 2015, Vol 6, No 5
in
ASCO 2015 Highlights
Adding Ibrutinib to Standard Therapy Reduces Disease Progression by 80% in Previously Treated Patients with CLL
Phoebe Starr
VBCC - June 2015, Vol 6, No 5
in
Palliative Care
Genomic Sequencing for Pancreatic Cancer Still Facing Hurdles
Phoebe Starr
VBCC - June 2015, Vol 6, No 5
in
Personalized Medicine
Pembrolizumab Scores Big Over Ipilimumab in Advanced Melanoma
Phoebe Starr
VBCC - May 2015, Vol 6, No 4
in
AACR Meeting Highlights
Two Immunotherapies Are Better Than One in Advanced Melanoma
Phoebe Starr
VBCC - May 2015, Vol 6, No 4
in
AACR Meeting Highlights
Liquid Biopsy Detects KRAS Mutations in Plasma DNA in Nonresectable Pancreatic Cancer, Can Predict Patient Outcomes
Phoebe Starr
VBCC - May 2015, Vol 6, No 4
in
AACR Meeting Highlights
Projections for 2030: Increase in ER-Positive, Decrease in ER-Negative Breast Cancer
Phoebe Starr
VBCC - May 2015, Vol 6, No 4
in
AACR Meeting Highlights
New Hope for Patients with Advanced Lung Cancer?
Phoebe Starr
VBCC - May 2015, Vol 6, No 4
in
AACR Meeting Highlights
ASSURE Trial: No Role for Adjuvant Sorafenib or Sunitinib in Locally Advanced Kidney Cancer
Phoebe Starr
VBCC - March 2015, Vol 6, No 2
in
Genitourinary Cancers Symposium
AR-V7 Predicts Chemotherapy Sensitivity in Metastatic Prostate Cancer
Phoebe Starr
VBCC - March 2015, Vol 6, No 2
in
Personalized Medicine
Caution: Active Surveillance Ill Advised in Men with Intermediate-Risk Prostate Cancer
Phoebe Starr
VBCC - March 2015, Vol 6, No 2
in
Genitourinary Cancers Symposium
History of Testicular Cancer Increases Risk for Aggressive Prostate Cancer Later on
Phoebe Starr
VBCC - March 2015, Vol 6, No 2
in
Genitourinary Cancers Symposium
Debate on PSA Prostate Cancer Screening Redux
Phoebe Starr
VBCC - March 2015, Vol 6, No 2
in
Genitourinary Cancers Symposium
Localized Renal Cancer Surgery Associated with Substantial Costs from Lost Productivity
Phoebe Starr
VBCC - March 2015, Vol 6, No 2
in
Genitourinary Cancers Symposium
Psychological Distress and Financial Burden Impact Adherence to CML Treatment
Phoebe Starr
VBCC - February 2015, ASH 2014 Highlights
in
Leukemia
Posttransplant Brentuximab: New Standard in Hodgkin Lymphoma?
Phoebe Starr
VBCC - February 2015, ASH 2014 Highlights
in
Lymphoma
Stem-Cell Transplant Safe in HIV-Related Lymphoma
Phoebe Starr
VBCC - February 2015, ASH 2014 Highlights
in
Lymphoma
Ovarian Function Suppression Reduces Recurrence in Premenopausal HR-Positive Breast Cancer
Phoebe Starr
VBCC - February 2015, Vol 6, No 1
in
Breast Cancer Symposium
Oncotype DX Clinically Validated for Risk Assessment in Patients with Ductal Carcinoma in Situ
Phoebe Starr
VBCC - February 2015, Vol 6, No 1
in
Breast Cancer Symposium
Mammographically Negative Dense Breasts Should Have Second Look with Ultrasound
Phoebe Starr
VBCC - February 2015, Vol 6, No 1
in
Breast Cancer Symposium
Venetoclax Moves Forward in Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia
Phoebe Starr
VBCC - February 2015, Vol 6, No 1
in
ASH 2014 Highlights
Secukinumab Promising in Ankylosing Spondylitis and PsA
Phoebe Starr
VBCR - December 2014, Volume 3, No 6
in
Rheumatology Update
Rethinking Herpes Zoster Vaccine in Patients with RA Taking Biologics
Phoebe Starr
VBCR - December 2014, Volume 3, No 6
in
Rheumatology Update
Use of Belimumab May Be Controversial in SLE
Phoebe Starr
VBCR - December 2014, Volume 3, No 6
in
Lupus
Novel Program Improves Quality of Care in RA, Reduces Cost
Phoebe Starr
VBCR - December 2014, Volume 3, No 6
in
Health Economics
Venetoclax Moves Forward in Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia
Phoebe Starr
VBCC - December 2014, Vol 5, No 10
in
ASH 2014 Highlights
Stem-Cell Transplant Safe in HIV-Related Lymphoma
Phoebe Starr
VBCC - December 2014, Vol 5, No 10
in
ASH 2014 Highlights
Posttransplant Brentuximab: New Standard of Care for Hodgkin Lymphoma?
Phoebe Starr
VBCC - December 2014, Vol 5, No 10
in
ASH 2014 Highlights
Preserving Sexual Function in Patients with Prostate Cancer with Vessel-Sparing Radiation Therapy
Phoebe Starr
VBCC - November 2014, Vol 5, No 9
in
Prostate Cancer
Risk for Second Primary Lung Cancers Remains High in Smokers
Phoebe Starr
VBCC - November 2014, Vol 5, No 9
in
Lung Cancer
Patient-Reported Outcomes Suggest Symptom Management Is Inadequately Addressed by Oncologists
Phoebe Starr
VBCC - November 2014, Vol 5, No 9
in
ASCO Quality Care Symposium
Radiation Safety Initiative Promises to Reduce Errors
Phoebe Starr
VBCC - November 2014, Vol 5, No 9
in
ASCO Quality Care Symposium
New Reimbursement Models Needed for Vulnerable Populations with Cancer
Phoebe Starr
VBCC - November 2014, Vol 5, No 9
in
Economics of Cancer Care
Financial Toxicity Beginning to Gain Oncologists’ Attention, Finally
Phoebe Starr
VBCC - November 2014, Vol 5, No 9
in
ASCO Quality Care Symposium
Brodalumab Shows Positive Results in Phase 2 Trial
Phoebe Starr
VBCR - October 2014, Volume 3, No 5
in
Psoriatic Arthritis
Sarilumab Promising in Patients with Rheumatoid Arthritis
Phoebe Starr
VBCR - October 2014, Volume 3, No 5
in
Rheumatoid Arthritis
CLEOPATRA: Record-Breaking Survival in HER2 Metastatic Breast Cancer by Adding Pertuzumab
Phoebe Starr
VBCC - October 2014, Vol 5, No 8
in
ESMO 2014 Highlights
Combination of BRAF and MEK Inhibitors Improves Survival in Patients with Advanced Melanoma
Phoebe Starr
VBCC - October 2014, Vol 5, No 8
in
ESMO 2014 Highlights
Record-Breaking Survival in HER2 Metastatic Breast Cancer by Adding Pertuzumab - Dual HER2 blockade a new standard of care
Phoebe Starr
VBCC - October 2014, Vol 5, No 8
in
ESMO 2014 Highlights
PD-1–Blocking Nivolumab Shows Impressive Responses in Melanoma
Phoebe Starr
VBCC - October 2014, Vol 5, No 8
in
ESMO 2014 Highlights
MiRNA Biomarkers Identified for Osteoarthritis Severity
Phoebe Starr
VBCR - August 2014, Volume 3, No 4
in
Osteoarthritis
Advances in Genotyping Pinpoints to Genetic Determinant
Phoebe Starr
VBCR - August 2014, Volume 3, No 4
in
Personalized Medicine in Rheumatology
Stopping Immunotherapy in Patients with Lupus
Phoebe Starr
VBCR - August 2014, Volume 3, No 4
in
Lupus
Biosimilars Make Headway in Rheumatoid Arthritis
Phoebe Starr
VBCR - August 2014, Volume 3, No 4
in
Rheumatoid Arthritis
Economic Outcomes Data on Adherence Lacking in Rheumatology
Phoebe Starr
VBCR - August 2014, Volume 3, No 4
in
Health Economics
Costs of Musculoskeletal Conditions Strain Healthcare Budgets
Phoebe Starr
VBCR - August 2014, Volume 3, No 4
in
Health Economics
Safety of Tofacitinib Stable Over Time
Phoebe Starr
VBCR - August 2014, Volume 3, No 4
in
Rheumatoid Arthritis
Reassuring Long-Term Safety for Biologics in Children with Juvenile Idiopathic Arthritis
Phoebe Starr
VBCR - August 2014, Volume 3, No 4
in
Juvenile Idiopathic Arthritis
ALTTO: Dual Anti-HER2 Adjuvant Therapy No Better than Trastuzumab Alone
Phoebe Starr
VBCC - August 2014 Vol 5, No 6
in
Breast Cancer
Nationwide Adoption of LDCT Screening Will Detect More Early-Stage Lung Cancer, but at Substantial Economic Cost
Phoebe Starr
VBCC - June 2014 Vol 5, No 5
in
ASCO 2014 Highlights
Obesity Ups Death Risk in Premenopausal Patients with ER-Positive, but Not ER-Negative, Breast Cancer
Phoebe Starr
VBCC - June 2014 Vol 5, No 5
in
ASCO 2014 Highlights
AZD9291, a Novel Mutation-Selective EGFR Inhibitor, May Overcome EGFR-TKI Resistance
Phoebe Starr
VBCC - June 2014 Vol 5, No 5
in
ASCO 2014 Highlights
Cetuximab versus Bevacizumab: Comparable Benefit as First-Line Therapy for Metastatic Colorectal Cancer
Phoebe Starr
VBCC - June 2014 Vol 5, No 5
in
ASCO 2014 Highlights
FGFR Inhibitor Shows Promising Anticancer Activity
Phoebe Starr
VBCC - May 2014 Vol 5, No 4
in
AACR Annual Meeting
Potential New Approach to Melanoma
Phoebe Starr
VBCC - May 2014 Vol 5, No 4
in
AACR Annual Meeting
PD-L1 Expression Potential Biomarker for Response to Immunotherapy with MK-3475
Phoebe Starr
VBCC - May 2014 Vol 5, No 4
in
Personalized Medicine
Simple Blood Test Predicts Response to Enzalutamide in Patients with Prostate Cancer
Phoebe Starr
VBCC - May 2014 Vol 5, No 4
in
Personalized Medicine
AG-221 Achieved Excellent Responses in Relapsed, Refractory Leukemia, Myelodysplastic Syndrome
Phoebe Starr
VBCC - May 2014 Vol 5, No 4
in
AACR Annual Meeting
Phi Index Can Select Patients with Prostate Cancer for Active Surveillance
Phoebe Starr
VBCC - April 2014 Vol 5, No 3
in
Prostate Cancer
Care of Patients with RA Varies Across the United States
Phoebe Starr
VBCR - April 2014, Volume 3, No 2
in
Rheumatoid Arthritis
Updated JIA Recommendations Unveiled
Phoebe Starr
VBCR - April 2014, Volume 3, No 2
in
Juvenile Idiopathic Arthritis
HPV Vaccination Rates Dismal in Patients with Autoimmune Diseases
Phoebe Starr
VBCR - April 2014, Volume 3, No 2
in
Autoimmune Diseases
Promising New Therapies in the Breast Cancer Pipeline
Phoebe Starr
VBCC - March 2014, Volume 5, No 2
in
VBCC Perspectives
Encouraging Long-Term Safety Data for Radium-223
Phoebe Starr
VBCC - March 2014, Volume 5, No 2
in
Prostate Cancer
Novel CAR-T Therapy Shows Impressive Results in Aggressive Leukemia, Lymphoma
Phoebe Starr
VBCC - February 2014, Volume 5, No 1
in
Personalized Medicine
Enzalutamide Extends Survival in Previously Untreated Metastatic Prostate Cancer
Phoebe Starr
VBCC - February 2014, Volume 5, No 1
in
Genitourinary Cancers Symposium
Anastrozole Cuts the Incidence of Breast Cancer by 50% in High-Risk Women
Phoebe Starr
VBCC - February 2014, Volume 5, No 1
in
SABCS 2014
Adjuvant Bisphosphonates: Winner in Postmenopausal Breast Cancer
Phoebe Starr
VBCC - February 2014, Volume 5, No 1
in
SABCS 2014
Angiotensin System Inhibitors Extend Survival in Patients with Metastatic Renal-Cell Carcinoma
Phoebe Starr
VBCC - February 2014, Volume 5, No 1
in
Genitourinary Cancers Symposium
Adding Radiation to Antiandrogen Hormone Therapy Extends Survival in Patients with High-Risk Prostate Cancer
Phoebe Starr
VBCC - February 2014, Volume 5, No 1
in
Genitourinary Cancers Symposium
1 in 5 US Clinical Trials Fails to Complete
Phoebe Starr
VBCC - February 2014, Volume 5, No 1
in
Genitourinary Cancers Symposium
I-SPY 2: First Results Based on Biomarkers/Genetic Signatures in Breast Cancer
Phoebe Starr
VBCC - February 2014, Volume 5, No 1
in
Personalized Medicine
Future Therapies May Come from Modulation of Cell Signaling in Rheumatic Disease
Phoebe Starr
VBCR - February 2014, Volume 3, No 1
in
Personalized Medicine in Rheumatology
Positive Results for CP-P13, Potential Biosimilar of Infliximab
Phoebe Starr
VBCR - February 2014, Volume 3, No 1
in
Rheumatoid Arthritis
Patients with Gout Often Do Not Meet Target Uric Acid Levels, Even with Treatment
Phoebe Starr
VBCR - February 2014, Volume 3, No 1
in
Gout
Hematologists Take Note: Do Not Misuse 5 Common Tests, Procedures
Phoebe Starr
VBCC - Other
Practice-Changing Results for Older, Sicker Patients with CLL
Phoebe Starr
VBCC - Other
Changing of the Guard in First-Line Treatment of Transplant-Ineligible Multiple Myeloma
Phoebe Starr
VBCC - Other
Reduced-Intensity Conditioning Avoids Transplant-Associated Cognitive Decline
Phoebe Starr
VBCC - Other
Survey Reveals Practice Gaps in Managing Patients with CML and B-Cell Lymphomas
Phoebe Starr
VBCC - Other
MPDL3280A: Responses Better in Smokers than in Nonsmokers in Advanced Lung Cancer
Phoebe Starr
VBCC - October 2013, Volume 4, No 8
in
ESMO 2013 Conference
Kadcyla Prolongs Survival in Advanced HER2-Positive Breast Cancer
Phoebe Starr
VBCC - October 2013, Volume 4, No 8
in
ESMO 2013 Conference
Second-Generation ALK Inhibitor Regresses Brain Metastases in Patients with Lung Cancer
Phoebe Starr
VBCC - October 2013, Volume 4, No 8
in
ESMO 2013 Conference
Role of Radiation and Imaging in DCIS Explained
Phoebe Starr
VBCC - October 2013, Volume 4, No 8
in
Breast Cancer Symposium
Genomics of Acute Myeloid Leukemia Explored
Phoebe Starr
VBCC - October 2013, Volume 4, No 8
in
Personalized Medicine
Idelalisib and Ibrutinib 2 Promising B-Cell Receptor–Signaling Inhibitors for B-Cell Malignancies
Phoebe Starr
VBCC - October 2013, Volume 4, No 8
in
Emerging Therapies
Two Genetic Tests Can Prevent Overtreatment of Early Prostate Cancer
Phoebe Starr
VBCC - July 2013, Volume 4, No 6
in
Personalized Medicine
Pazopanib: First Positive Maintenance Trial in Ovarian Cancer
Phoebe Starr
VBCC - June 2013, Volume 4, No 5
in
ASCO Annual Meeting
Pazopanib: First Positive Maintenance Trial in Ovarian Cancer
Phoebe Starr
VBCC - News
AACR Issues New Policy on Tobacco Use
Phoebe Starr
VBCC - May 2013, Volume 4, No 4
in
AACR Annual Meeting
Novel Immunotherapy Approach Encouraging in Advanced Ovarian Cancer
Phoebe Starr
VBCC - May 2013, Volume 4, No 4
in
Ovarian Cancer
Higher HER2 Expression Leads to Better Outcomes with T-DM1 in Patients with Metastatic Breast Cancer
Phoebe Starr
VBCC - May 2013, Volume 4, No 4
in
Personalized Medicine
Postorchiectomy Surveillance Less Cost-Effective than Other Management Options
Phoebe Starr
VBCC - March 2013, Volume 4, No 3
in
Health Economics
Similar Outcomes with 18 Months versus 36 Months of Androgen Ablation Added to Radiation in High-Risk Prostate Cancer
Phoebe Starr
VBCC - March 2013, Volume 4, No 3
in
Genitourinary Cancers Symposium
Surveillance an Option for Small Renal Masses in the Elderly
Phoebe Starr
VBCC - March 2013, Volume 4, No 3
in
Genitourinary Cancers Symposium
Targeted Therapies Added to Docetaxel Don’t Extend Survival in Metastatic Prostate Cancer
Phoebe Starr
VBCC - March 2013, Volume 4, No 3
in
Genitourinary Cancers Symposium
SNPs in Genes Affect Quality of Life Related to Radiation in Men with Prostate Cancer
Phoebe Starr
VBCC - March 2013, Volume 4, No 3
in
Personalized Medicine
Molecular Assays Reclassify Early Breast Cancer Type
Phoebe Starr
VBCC - February 2013, Volume 4, No 2
in
Personalized Medicine
A New Multigene Score Identifies Women with ER-Positive Breast Cancer at Risk for Late Metastases
Phoebe Starr
VBCC - February 2013, Volume 4, No 2
in
Personalized Medicine
Women with Triple-Negative Breast Cancer Very Likely to Carry BRCA1 Gene
Phoebe Starr
VBCC - February 2013, Volume 4, No 2
in
Personalized Medicine
Real-World Evidence Shows Impact of Musculoskeletal Toxicity of Aromatase Inhibitors on Women with Breast Cancer
Phoebe Starr
VBCC - February 2013, Volume 4, No 2
in
Breast Cancer
Black Women with Invasive Node-Negative Breast Cancer Less Likely to Get Sentinel Lymph Node Biopsy for Axillary Staging, More Likely to Have Lymphedema
Phoebe Starr
VBCC - January 2013, Volume 4, No 1
in
Breast Cancer
Stereotactic Body Radiation Therapy Cost-Saving, Convenient for Patients with Prostate Cancer
Phoebe Starr
VBCC - November 2012, Volume 3, No 8
in
ASTRO Annual Meeting
Proton Beam Therapy: Similar Toxicity to Standard Radiation, at Much Higher Cost
Phoebe Starr
VBCC - November 2012, Volume 3, No 8
in
ASTRO Annual Meeting
Newer, More Costly Radiation Technologies Adopted in Elderly Patients with Breast Cancer
Phoebe Starr
VBCC - November 2012, Volume 3, No 8
in
ASTRO Annual Meeting
Platinum-Resistant Ovarian Cancer: Bevacizumab Improves Survival When Added to Chemotherapy
Phoebe Starr
VBCC - November 2012, Volume 3, No 8
in
ESMO 2012 Conference
Updated Data Confirm Survival Benefits with T-DM1 in Breast Cancer and with Regorafenib in Colon Cancer
Phoebe Starr
VBCC - October 2012, Volume 3, No 7
in
ESMO 2012 Conference
New Drugs for the Treatment of Prostate Cancer
Phoebe Starr
VBCC - October 2012, Volume 3, No 7
in
ESMO 2012 Conference
Economics Impede Growth of Supportive Care Services
Phoebe Starr
VBCC - September 2012, Volume 3, No 6
in
MASCC Symposium
Observation as Good as Radical Surgery for Localized Prostate Cancer, Especially Low-Risk Cancer
Phoebe Starr
VBCC - September 2012, Volume 3, No 6
in
Prostate Cancer
Molecularly Targeted Agents Have Lower Rates of Severe Diarrhea than Standard Chemotherapy
Phoebe Starr
VBCC - September 2012, Volume 3, No 6
in
Health Policy
Biomarker Identifies Patients with Rare Brain Tumors Who Have a Survival Benefit from Chemotherapy Plus Radiation
Phoebe Starr
VBCC - June 2012, Volume 3, No 4
in
ASCO Annual Meeting
Long-Term Survivors of Hematopoietic Stem-Cell Transplant Pose Significant Burden to Healthcare System
Phoebe Starr
VBCC - March 2012, Volume 3, No 2
in
ASH Annual Meeting
Nonpharmacologic Strategies Have Mixed Results in Prostate Cancer Prevention
Phoebe Starr
VBCC - March 2012, Volume 3, No 2
in
Genitourinary Cancers Symposium
Which Patients with Prostate Cancer Should Receive Hormone Therapy in Addition to Radiation?
Phoebe Starr
VBCC - February 2012, Volume 3, No 1
in
Prostate Cancer
Array of Treatments for Metastatic Prostate Cancer, but Can We Afford Them?
Phoebe Starr
VBCC - February 2012, Volume 3, No 1
in
Genitourinary Cancers Symposium
Hypofractionated Radiotherapy in Prostate Cancer More Convenient for Patients
Phoebe Starr
VBCC - December 2011, Volume 2, No 7
in
ASTRO Annual Meeting
“Pediatric-Inspired” Regimens Improve Outcomes in Adults with ALL
Phoebe Starr
VBCC - December 2011, Volume 2, No 7
in
NCCN Conference
Role of Adjuvant Zoledronic Acid in Endocrine Receptor- Positive Breast Cancer Being Refined
Phoebe Starr
VBCC - December 2011, Volume 2, No 7
in
CTRC-AACR SABCS Annual Meeting
Reporting Gap for Near-Misses and Errors in Radiation Oncology Is Rampant
Phoebe Starr
VBCC - December 2011, Volume 2, No 7
in
ASTRO Annual Meeting
High-Dose Radiation Does Not Improve Survival in Stage III NSCLC
Phoebe Starr
VBCC - December 2011, Volume 2, No 7
in
ASTRO Annual Meeting
Novel Agents Improve Outcomes as Maintenance Therapy for Multiple Myeloma
Phoebe Starr
VBCC - October 2011, Volume 2, No 6
in
NCCN Hematology Congress
Treatment Delay Feasible in Asymptomatic Follicular Lymphoma
Phoebe Starr
VBCC - October 2011, Volume 2, No 6
in
NCCN Hematology Congress
Advances in the Management of Chronic Lymphocytic Leukemia
Phoebe Starr
VBCC - October 2011, Volume 2, No 6
in
NCCN Hematology Congress
Progress in Molecular Markers that Predict Prognosis in AML
Phoebe Starr
VBCC - October 2011, Volume 2, No 6
in
NCCN Hematology Congress
Last modified: October 18, 2011
Home
Issues
2018
April 2018, Vol 7, No 1
2017
December 2017, Vol 6, No 5
October 2017, Vol 6, No 4
August 2017, Vol 6, No 3
June 2017, Vol 6, No 2
April 2017, Vol 6, No 1
2016
December 2016, Vol 5, No 6
October 2016, Vol 5, No 5
August 2016, Vol 5, No 4
June 2016, Vol 5, No 3
April 2016, Vol 5, No 2
February 2016, Vol 5, No 1
Issues Archive
Supplements
Categories
Web Exclusives
All Web Exclusives
FDA Approvals, News & Updates
In The News
Online First
Videos
About
About VBCR
About Engage HC
Contact Us
Editorial/Publishing Policies
Editorial Board
Advertising Contacts
Advertising Policy
Author Guidelines